Reunion Neuroscience, Inc. — Form D/A

Reunion Neuroscience, Inc. of MORRISTOWN, NJ, a company, filed a Form D amendment with the SEC on 2025-09-09. The offering totals $119.8M, of which $119.8M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2025-09-09
Form: D/A
Accession: 0002007993-25-000004
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $119.8M
Amount sold: $119.8M
Investors: 9
Date of first sale: 2024-01-12
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-503441

Issuer

Name: Reunion Neuroscience, Inc.
CIK: 0002007993
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2023
Address: 1 HIGH STREET COURT, MORRISTOWN, NJ, 07960
Phone: 888-880-7386

Officers, directors & promoters (13)

Name	Role	Location
Michael Ehlers	Director	Morristown, NJ
Ansbert Gadicke	Director	Morristown, NJ
Alon Lazarus	Director	Cambridge, MA
Ellen Lubman	Director	Morristown, NJ
Gregory Mayes	Director	Morristown, NJ
Natalie Sacks	Director	Morristown, NJ
Nathan Bryson	Executive Officer	Morristown, NJ
Gregory Mayes	Executive Officer	Morristown, NJ
Mark Pollack	Executive Officer	Morristown, NJ
Edward Smith	Executive Officer	Norwalk, CT
Mark Theeuwes	Executive Officer	Morristown, NJ
Briggs Morrison	Director	Cambridge, MA
Robert Alexander	Executive Officer	Boston, MA

Other filings by this issuer (3)

Filed	Form	Offering	Sold
2025-05-05	D/A	$89.8M	$68.9M
2024-05-06	D/A	$89.8M	$33.7M
2024-01-25	D	$66.8M	$16.9M

More